Description
The inclusion of DAC in CBS Product #CwD10 optimizes the peptide’s pharmacokinetics, ensuring prolonged effects and sustained release. Researchers utilizing this product can explore its efficacy in growth hormone modulation and related therapeutic areas. CJC-1295 with CBS Product #CwD10 features CJC-1295 with Dac, a potent peptide designed to enhance growth hormone release and promote overall growth and recovery in various applications. This formulation is intended for research purposes and aims to provide significant benefits in the study of peptide therapy. DAC 10 MG
CJC-1295 (with DAC), also known as Modified GRF (1-29), is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH). The modifications at positions 2, 8, 15, and 27 confer resistance to enzymatic degradation, extending its biological half-life while maintaining the natural pulsatile GH release pattern.
Molecular Profile:
- Molecular Weight: 3,367.9 g/mol
- Sequence: Modified GRF (1-29) with D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ substitutions
- CAS Number: 863288-34-0
Research Applications:
- Pulsatile GH release pattern investigation
- GHRH receptor binding and signaling studies
- IGF-1 axis stimulation research
- Sleep-associated GH secretion analysis
- Metabolic rate and body composition studies
Quality Standards:
- Purity: ≥99% verified by HPLC
- Third-party tested with COA included
FOR RESEARCH USE ONLY. Not for human consumption.
